Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc orotate is a compound consisting of zinc bound to orotic acid. It is primarily used as a dietary supplement to address and prevent zinc deficiency. Zinc is an essential trace element involved in numerous biological processes, including immune function, metabolism, enzyme activity, and cellular signaling[1][2][5]. The orotate form is believed to facilitate the transport of zinc across cell membranes more efficiently than some other forms due to its unique carrier properties[6]. Zinc orotate dissociates at the level of cytoplasmic structures such as mitochondria, releasing bioavailable ionic zinc within cells[6]. There are claims that it may be better tolerated with fewer side effects compared to other forms of supplemental zinc; however, robust clinical evidence for superiority over other forms remains limited[6]. Zinc orotate has been explored experimentally for potential roles in supporting immune health and possibly influencing conditions associated with low intracellular zinc levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc orotate.